![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Welcome back to Endpoints Weekly. Grab a cup of Saturday morning coffee and let’...
GSK has snagged FDA approval for its 5-in-1 meningococcal vaccine, propelling it...
Eli Lilly has shared first-in-human results for its selective FGFR3 inhibitor in...
The Trump administration’s effort to remake the federal workforce swept through ...
Johnson & Johnson is set to push for confirmation of a bankruptcy plan next week...
Renee Wegrzyn has been let go as the head of a federal agency that pursues ambit...
Major drugmakers are planning to meet with President Donald Trump next week at t...
Kojin Therapeutics, a startup attempting to develop new treatments using program...
West Pharmaceuticals Services’ stock {$WST} tanked by as much as 38% late Thursd...
Corbus Pharmaceuticals reported encouraging early-stage results for its Nectin-4...
Plus, news about Aardvark’s IPO: Otsuka cuts cancer programs: The drugmaker ...
A new immunology biotech closed its Series A, and it’s backed by investors intri...
About two and a half years before they sealed a $3.3 billion deal, Bain Capital ...
Moderna is working on restoring investors' faith that its Covid-19 vaccine was n...
David Schenkein will step down from Agios Pharmaceuticals’ board of directors at...
Bristol Myers Squibb’s LAG-3/PD-1 targeting immunotherapy Opdualag failed to boo...